Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stock Ready To Explode!


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Alterity Therapeutics (NASDAQ:ATHE) Stock Continues to Trade in a Range After The Recent Fall

Shares of Alterity Therapeutics (NASDAQ:ATHE) continues to consolidate after the recent development. Market Stats On Friday, ATHE stock moved down 3.97% at $1.2100 with more than 332.97K shares, compared to its average volume of 525.80K shares. The stock has moved within a range of $1.2100 – 1.2800 after opening the trade at $1.2300. New Publications …

Alterity Therapeutics (NASDAQ:ATHE) Stock Sees Selling Pressure At Higher Level: What To Do?

Back on July 1, the Alterity Therapeutics (NASDAQ:ATHE) stock had come into considerable focus among investors after it emerged that the United States Patent and Trademark Office had awarded it a fresh composition of matter patent. It was a major development for the company but at the same time investors also need to recognise the …

Alterity Therapeutics (NASDAQ:ATHE) Stock Pulls Back on Profit Booking: Time To Buy?

When a stock records strong gains then it is almost a certainty that a bit of profit book is going to lead to a correction and that is what seemed to have happened with the Alterity Therapeutics Ltd (NASDAQ:ATHE) stock on Wednesday. Yesterday, a bit of profit taking from investors resulted in a 5% decline …